Corinne Savill

Corinne Savill

Corporate Officer/Principal chez CULLINAN THERAPEUTICS, INC.

Fortune : 4 M $ au 31/05/2026

66 ans
Health Technology
Consumer Services
Finance

Profil

Corinne Savill currently works at Cullinan Therapeutics, Inc., as Chief Business Officer from 2017.
Dr. Savill also formerly worked at Imutran Ltd., as Chief Executive Officer from 1997 to 2001, Cantargia AB, as Director in 2018, Novartis Pharmaceuticals Corp., as Head-Business Development & Licensing, Novartis Pharma AG, as Global Head-Business Development & Licensing from 2013 to 2017, and Cullinan Oncology LLC, as Chief Business Officer.
Dr. Savill received her undergraduate degree from The University of Manchester and doctorate degree from Middlesex School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
18/02/2026 240 990 ( 0,41% ) 4 M $ 31/05/2026

Postes actifs de Corinne Savill

SociétésPosteDébut
CULLINAN THERAPEUTICS, INC. Corporate Officer/Principal 01/02/2017

Anciens postes connus de Corinne Savill

SociétésPosteFin
CANTARGIA AB Directeur/Membre du Conseil 21/05/2018
Corporate Officer/Principal 01/02/2017
Directeur Général 01/01/2001
Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Corinne Savill

Formation de Corinne Savill

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

12

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Finance

Health Technology

Miscellaneous

  1. Bourse
  2. Insiders
  3. Corinne Savill
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT